{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-265861","form_type":"8-K","ticker":"EIKN","cik":"0001861123","company_name":"Eikon Therapeutics, Inc.","filed_at":"2026-06-10T20:15:32+00:00","discovered_at":"2026-06-10T20:17:00.345159+00:00","generated_at":"2026-06-10T20:23:52.667696+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Eikon Therapeutics appoints Ma. Fatima D. Francisco to Board as Class I director","bullets":["Appointment effective June 15, 2026; serves until 2027 annual meeting.","Annual retainer of $50,000 paid quarterly; initial option for 85,937 shares at $8.96.","Option vests in 48 equal monthly installments subject to continued service.","Ms. Francisco will serve on the Compensation Committee of the Board.","No arrangements or related-person transactions with the Company disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-265861","json":"https://secwatch.observer/filing/0001193125-26-265861.json","markdown":"https://secwatch.observer/filing/0001193125-26-265861.md","text":"https://secwatch.observer/filing/0001193125-26-265861.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1861123/000119312526265861/0001193125-26-265861-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1861123/000119312526265861/eikn-20260605.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T20:23:52.667696+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"719fc341b0","claim":"Ma. Fatima D. Francisco was appointed as Class I director at Eikon Therapeutics, Inc..","evidence_excerpt":"the Board of Directors (the “Board”) of Eikon Therapeutics, Inc. (the “Company”) appointed Ma. Fatima D. Francisco to the Board as a Class I director, effective June 15, 2026.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1861123/000119312526265861/0001193125-26-265861-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class I director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}